Inventor · disambiguated record
Jie Su
Also filed as: SU JIE
5 granted patents·8 pending applications·0 citations·filing 2018–2024
60Inventor score
Files withACCUTAR BIOTECHNOLOGY INC6TIGER BIOTHERAPEUTICS INC4GENERATION BIO CO2PEG BIO BIOPHARM CO LTD CHONGQING1
Top patents by PatentIndex Score
13 records- 0179US12195459B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Granted Jan 14, 2025·0 cites·46 claims
- 0279US12110291B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·32 claims
- 0377US2025092039A1Glutarimide-containing pan-kras-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0470US12168058B2Glutarimide-containing KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·0 cites·47 claims
- 0569US12338248B2Aminopyrimidine derivatives as cyclin-dependent kinase inhibitorsACCUTAR BIOTECHNOLOGY INC·Filed 2024·Granted Jun 24, 2025·0 cites·48 claims
- 0667US2024317777A1Novel macrocyclic aminopyrazole compounds as cdk2 inhibitorsACCUTAR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 0765US2024208909A1Substituted quinoline derivatives having sos1 inhibition activities and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 0864US2025352548A1BTK Reducing Molecules for Treatment of Cancers and Immune System DisordersACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 0963US2024150424A1Directed chemical conjugate of glucagon-like peptide-2 mutant, and use thereofPEG BIO BIOPHARM CO LTD CHONGQING·Filed 2024·Application pending·0 cites
- 1061US11530222B2Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degradersACCUTAR BIOTECHNOLOGY INC·Filed 2022·Granted Dec 20, 2022·0 cites·30 claims
- 1161US2024059698A1Heteroaryl compounds as egfr inhibitors and their usesACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 1245US2022280427A1Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereofGENERATION BIO CO·Filed 2020·Application pending·0 cites
- 1344US2021059953A1Lipid nanoparticle formulations of non-viral, capsid-free dna vectorsGENERATION BIO CO·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jie Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →